The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges

Author： Ahmed Mohamed H   Al-Atta Ayman   Hamad Mahir A  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.13, 2012-09, pp. : 1901-1909

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statins: Monotherapy or Combination Strategy for the Treatment of Dyslipidemia

By  

Heart Drug, Vol. 2, Iss. 4, 2002-11 ,pp. : 175-183

Karger

Access to resources Recommend Favorite

Treatment of dyslipidemia in HIV-infected patients

By Sekhar Rajagopal V   Balasubramanyam Ashok  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1845-1854

Informa Healthcare

Access to resources Recommend Favorite

Fenofibrate in the treatment of dyslipidemia associated with HIV infection

By Samineni Divya   Fichtenbaum Carl J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 8, 2010-08 ,pp. : 995-1004

Informa Healthcare

Access to resources Recommend Favorite

Safety of Sumatriptan in Pregnancy: A Review of the Data So Far

By Loder E.  

CNS Drugs, Vol. 17, Iss. 1, 2003-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

Anti-HIV Drug Development: Structural Features and Limitations of Present Day Drugs and Future Challenges in the Successful HIV/AIDS Treatment

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1767-1783

Bentham Science Publishers

Access to resources Recommend Favorite